Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - 22.12.2015

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : Glenmark Pharmaceuticals Inc Forest Laboratories LLC Forest Laboratories Holdings Royalty Pharma Collection Trust

Share :